- Titre
- Pretreatment by omalizumab allows allergen-specific immunotherapy in children and young adult with severe allergic asthma
- Créateurs - sans rôle
- Nathalie Lambert - Armand Trousseau Children's Hospital, Allergology Department, Paris, FranceTamazoust Guiddir - Armand Trousseau Children's Hospital, Allergology Department, Paris, FranceJocelyne Just - Armand Trousseau Children's Hospital, Allergology Department, Paris, FranceFlore Amat - Armand Trousseau Children's Hospital, Allergology Department, Paris, France
- Détails de publication
- Clinical and translational allergy, Vol.5(Suppl 2), pp.P1-P1
- Éditeur
- BioMed Central
- Identifiants
- 99150118309311
- Unité académique
- Institut Desbrest d Epidemiologie et de Sante Publique - IDESP
- Langue
- English
- Type de ressource
- Journal article
Article de revue
Pretreatment by omalizumab allows allergen-specific immunotherapy in children and young adult with severe allergic asthma
Clinical and translational allergy, Vol.5(Suppl 2), pp.P1-P1
23/03/2015
Indicateurs
1 Consultations de la notice